Glenmark Pharmaceuticals receives ANDA approval for anti-herpes ointment
Glenmark Pharmaceuticals has received the final ANDA approval from the United States Food and Drug Administration (USFDA) to market Acyclovir […]
Glenmark Pharmaceuticals has received the final ANDA approval from the United States Food and Drug Administration (USFDA) to market Acyclovir […]
Global pharma major Cipla today announced the launch of Artesunate Rectal Artesunate Suppositories (RAS) in a strength of 100 mg […]
India has proven capabilities in the generic drug formulations, but over dependence on China for sourcing 70-75 per cent of […]
Pharmaceutical industry is more reactive than pro-active in technology adoption, primarily because of tight regulations and domain complexities. As it […]
Kewal Handa Managing Director, Pfizer Ltd Kewal Handa is recognised as an industry expert on issues concerning the pharmaceutical sector. […]
Biocon , India’s top-listed biotechnology company, expects to generate larger licensing income from pharmaceuticals business, its Chairman and Managing Director […]
Gynesonics has begun a multicentre clinical trial to assess the effectiveness of the VizAblate system for the treatment of uterine […]
Global pharma giant GlaxoSmithKline is eyeing acquisitions worth $ 2 billion in India, the world’s fastest-growing drug market, media reports […]
With a hospital information system already in place, Manipal Hospitals is planning an expansion spree by connecting all its hospitals through an HIS. Dr Nagendra Swamy oversees, among other responsibilities, the functioning and operations of the Bangalore Cluster of Manipal Hospitals.
Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today on receiving recognition from The Rotary Foundation of Rotary International.
Recent analysis shows that the high priced research and development companies which show $1.3 billion cost are not real.
President and Managing Director, MSD Pharmaceuticals Limited K G Ananthakrishnan and leading paedetrician, Dr Manjira Mitra, announced the national launch of the unique health product in India.
Aurbindo pharma looses 0.91 percent stakes possessed by HSBC Global Investment Funds (Mauritius) Ltd in the open market sales.